291 related articles for article (PubMed ID: 25953156)
41. Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.
Yao RS; Lu XQ; Guan QX; Zheng L; Lu X; Ruan BF
Eur J Med Chem; 2013 Apr; 62():222-31. PubMed ID: 23353741
[TBL] [Abstract][Full Text] [Related]
42. Synthesis of Novel Pyrido[1,2-a]pyrimidine-3-carboxamide Derivatives and Their Anticancer Activity.
Santhosh Kumar G; Jitender Dev G; Ravi Kumar N; Krishna Swaroop D; Poorna Chandra Y; Ganesh Kumar C; Narsaiah B
Chem Pharm Bull (Tokyo); 2015; 63(8):584-90. PubMed ID: 26235166
[TBL] [Abstract][Full Text] [Related]
43. Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.
Zhang L; Shi L; Soars SM; Kamps J; Yin H
J Med Chem; 2018 Jul; 61(14):5881-5899. PubMed ID: 29870245
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
Mallavadhani UV; Prasad CV; Shrivastava S; Naidu VG
Eur J Med Chem; 2014 Aug; 83():84-91. PubMed ID: 24953027
[TBL] [Abstract][Full Text] [Related]
45. Design and synthesis of novel 6-hydroxy-4-methoxy-3-methylbenzofuran-7-carboxamide derivatives as potent Mnks inhibitors by fragment-based drug design.
Wang S; Li B; Liu B; Huang M; Li D; Guan L; Zang J; Liu D; Zhao L
Bioorg Med Chem; 2018 Sep; 26(16):4602-4614. PubMed ID: 30115493
[TBL] [Abstract][Full Text] [Related]
46. Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety.
Ma Y; Zheng X; Gao H; Wan C; Rao G; Mao Z
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941680
[TBL] [Abstract][Full Text] [Related]
47. Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.
Jin L; Zhang B; Hua S; Ji M; Huang X; Huang R; Wang H
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3700-3707. PubMed ID: 30528976
[TBL] [Abstract][Full Text] [Related]
48. Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents.
Jo H; Choi M; Kumar AS; Jung Y; Kim S; Yun J; Kang JS; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
ACS Med Chem Lett; 2016 Apr; 7(4):385-90. PubMed ID: 27096046
[TBL] [Abstract][Full Text] [Related]
49. C5-Modified nucleosides exhibiting anticancer activity.
Lee YS; Park SM; Kim HM; Park SK; Lee K; Lee CW; Kim BH
Bioorg Med Chem Lett; 2009 Aug; 19(16):4688-91. PubMed ID: 19596579
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis and in vivo anticancer activity of novel parthenolide and micheliolide derivatives as NF-κB and STAT3 inhibitors.
Zeng B; Cheng Y; Zheng K; Liu S; Shen L; Hu J; Li Y; Pan X
Bioorg Chem; 2021 Jun; 111():104973. PubMed ID: 34004586
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy.
Qiu P; Zhang S; Zhou Y; Zhu M; Kang Y; Chen D; Wang J; Zhou P; Li W; Xu Q; Jin R; Wu J; Liang G
Eur J Med Chem; 2017 Oct; 139():917-925. PubMed ID: 28881286
[TBL] [Abstract][Full Text] [Related]
52. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
53. Thiophene-3-carboxamide analogue of annonaceous acetogenins as antitumor drug lead.
Kojima N; Fushimi T; Tatsukawa T; Tanaka T; Okamura M; Akatsuka A; Yamori T; Dan S; Iwasaki H; Yamashita M
Eur J Med Chem; 2014 Oct; 86():684-9. PubMed ID: 25226228
[TBL] [Abstract][Full Text] [Related]
54. Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera.
Lee JH; Jung HS; Giang PM; Jin X; Lee S; Son PT; Lee D; Hong YS; Lee K; Lee JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):271-8. PubMed ID: 16183703
[TBL] [Abstract][Full Text] [Related]
55. First Bispecific Inhibitors of the Epidermal Growth Factor Receptor Kinase and the NF-κB Activity As Novel Anticancer Agents.
Hamed MM; Darwish SS; Herrmann J; Abadi AH; Engel M
J Med Chem; 2017 Apr; 60(7):2853-2868. PubMed ID: 28291344
[TBL] [Abstract][Full Text] [Related]
56. Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.
Al-Sanea MM; Al-Ansary GH; Elsayed ZM; Maklad RM; Elkaeed EB; Abdelgawad MA; Bukhari SNA; Abdel-Aziz MM; Suliman H; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):987-999. PubMed ID: 33985397
[TBL] [Abstract][Full Text] [Related]
57. First synthesis and anticancer activity of novel naphthoquinone amides.
Pradidphol N; Kongkathip N; Sittikul P; Boonyalai N; Kongkathip B
Eur J Med Chem; 2012 Mar; 49():253-70. PubMed ID: 22280818
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
Xu F; Jia Y; Wen Q; Wang X; Zhang L; Zhang Y; Yang K; Xu W
Eur J Med Chem; 2013 Jun; 64():377-88. PubMed ID: 23644219
[TBL] [Abstract][Full Text] [Related]
60. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
Kim HR; Park CG; Jung JY
Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
